Literature DB >> 11450280

Lower respiratory tract infections in Inuit infants on Baffin Island.

A Banerji1, A Bell, E L Mills, J McDonald, K Subbarao, G Stark, N Eynon, V G Loo.   

Abstract

BACKGROUND: It has long been suspected that Canadian Inuit children suffer from frequent severe lower respiratory tract infections (LRTIs), but the causes and risk factors have not been documented. This study assessed the infectious causes and other epidemiologic factors that may contribute to the severity of LRTI in young Inuit children on Baffin Island.
METHODS: A prospective case study was carried out at the Baffin Regional Hospital in Iqaluit, Nunavut, of infants less than 6 months of age, who were admitted to hospital between October 1997 and June 1998 with a diagnosis of LRTI. Immunofluorescent antibody testing was used to identify respiratory viruses, and enzyme immunoassay (EIA) and polymerase chain reaction (PCR) were used to test for Chlamydia trachomatis. Demographic and risk factor data were obtained through a questionnaire.
RESULTS: The annualized incidence rate of admission to hospital for bronchiolitis at Baffin Regional Hospital was 484 per 1000 infants who were less than 6 months of age; 12% of the infants were intubated. Probable pathogens were identified for 18 of the 27 cases considered in our study. A single agent was identified for 14 infants: 8 had respiratory syncytial virus, 2 adenovirus, 1 rhinovirus, 1 influenza A, 1 parainfluenza 3 and 1 had cytomegalovirus. For 4 infants, 2 infectious agents were identified: these were enterovirus and Bordetella pertussis, adenovirus and enterovirus, cytomegalovirus and respiratory syncytial virus, and respiratory syncytial virus and adenovirus. C. trachomatis was not identified by either EIA or PCR. All infants were exposed to maternal smoking in utero, second-hand smoke at home and generally lived in crowded conditions.
INTERPRETATION: Inuit infants in the Baffin Region suffer from an extremely high rate of hospital admissions for LRTI. The high frequency and severity of these infections calls for serious public health attention.

Entities:  

Mesh:

Year:  2001        PMID: 11450280      PMCID: PMC81192     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  14 in total

1.  Severity of lung disease in Indian children.

Authors:  C S Houston; R L Weiler; B F Habbick
Journal:  Can Med Assoc J       Date:  1979-05-05       Impact factor: 8.262

2.  Bronchiectasis in Alaska Native children.

Authors:  J K Fleshman; J F Wilson; J J Cohen
Journal:  Arch Environ Health       Date:  1968-10

3.  Lower respiratory illness among Alaskan Eskimo children.

Authors:  J A Brody
Journal:  Arch Environ Health       Date:  1965-11

4.  Severe respiratory syncytial virus disease in Alaska native children. RSV Alaska Study Group.

Authors:  R A Karron; R J Singleton; L Bulkow; A Parkinson; D Kruse; I DeSmet; C Indorf; K M Petersen; D Leombruno; D Hurlburt; M Santosham; L H Harrison
Journal:  J Infect Dis       Date:  1999-07       Impact factor: 5.226

5.  High rates of hospitalisation for bronchiolitis in Inuit children on Baffin Island.

Authors:  A Banerji
Journal:  Int J Circumpolar Health       Date:  2001-08       Impact factor: 1.228

6.  Increased incidence of bronchial reactivity in children with a history of bronchiolitis.

Authors:  D Gurwitz; C Mindorff; H Levison
Journal:  J Pediatr       Date:  1981-04       Impact factor: 4.406

7.  Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up.

Authors:  D M Brasfield; S Stagno; R J Whitley; G Cloud; G Cassell; R E Tiller
Journal:  Pediatrics       Date:  1987-01       Impact factor: 7.124

8.  Hospitalizations for respiratory syncytial virus infection in Alaska Native children.

Authors:  R J Singleton; K M Petersen; J E Berner; E Schulte; K Chiu; C M Lilly; E A Hughes; L R Bulkow; T L Nix
Journal:  Pediatr Infect Dis J       Date:  1995-01       Impact factor: 2.129

9.  Chlamydia trachomatis and chronic respiratory disease in childhood.

Authors:  H R Harrison; L M Taussig; V A Fulginiti
Journal:  Pediatr Infect Dis       Date:  1982 Jan-Feb

10.  Pulmonary assessment of children after chlamydial pneumonia of infancy.

Authors:  S G Weiss; R W Newcomb; M O Beem
Journal:  J Pediatr       Date:  1986-05       Impact factor: 4.406

View more
  28 in total

1.  A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice.

Authors:  Bosco A Paes; Ian Mitchell; Anna Banerji; Krista L Lanctôt; Joanne M Langley
Journal:  Can Respir J       Date:  2011 Mar-Apr       Impact factor: 2.409

2.  Cost-effectiveness of palivizumab compared to no prophylaxis in term infants residing in the Canadian Arctic.

Authors:  Anna Banerji; Kaspar Ng; Theo J Moraes; Vladimir Panzov; Joan Robinson; Bonita E Lee
Journal:  CMAJ Open       Date:  2016-10-18

3.  Preventing hospitalizations for respiratory syncytial virus infection.

Authors:  Joan L Robinson; Nicole Le Saux
Journal:  Paediatr Child Health       Date:  2015 Aug-Sep       Impact factor: 2.253

4.  The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study.

Authors:  Michelle L Butt; Amanda Symington; Marianne Janes; Louann Elliott; Susan Steele; Bosco A Paes
Journal:  Eur J Pediatr       Date:  2010-12-22       Impact factor: 3.183

5.  Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study.

Authors:  Anna Banerji; Val Panzov; Michael Young; Joan Robinson; Bonita Lee; Theo Moraes; Muhammad Mamdani; B Louise Giles; Depeng Jiang; Danny Bisson; Marguerite Dennis; Johanne Morel; Judith Hall; Charles Hui; Bosco Paes; James B Mahony
Journal:  CMAJ Open       Date:  2016-10-17

6.  Respiratory disease in Canadian First Nations and Inuit children.

Authors:  Thomas Kovesi
Journal:  Paediatr Child Health       Date:  2012-08       Impact factor: 2.253

7.  Long-term management of asthma in First Nations and Inuit children: A knowledge translation tool based on Canadian paediatric asthma guidelines, intended for use by front-line health care professionals working in isolated communities.

Authors:  Tom Kovesi; Brenda Louise Giles; Hans Pasterkamp
Journal:  Paediatr Child Health       Date:  2012-08       Impact factor: 2.253

8.  Prophylaxis of respiratory syncytial virus in Canada in 2003.

Authors:  Joan L Robinson; Bonita E Lee
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

9.  The real-life effectiveness of palivizumab for reducing hospital admissions for respiratory syncytial virus in infants residing in Nunavut.

Authors:  Anna Banerji; Vladimir Panzov; Michael Young; Bonita E Lee; Muhammad Mamdani; B Louise Giles; Marguerite Dennis; Johanne Morel; Danny Bisson; Bosco A Paes; Charles Hui; Jim Mahony
Journal:  Can Respir J       Date:  2013-12-23       Impact factor: 2.409

10.  Hospital admission rates for lower respiratory tract infections in infants in the Northwest Territories and the Kitikmeot region of Nunavut between 2000 and 2004.

Authors:  Michael Young; Kami Kandola; Ryan Mitchell; Anthony Leamon
Journal:  Paediatr Child Health       Date:  2007-09       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.